TABLE OF CONTENTS
Volume 12, Issue 2 (January 2006)
Editorial
Editorial: Much ado about nothing
Simon Bright and Nigel Poole
J Commer Biotechnol 12: 83-84; doi:10.1057/palgrave.jcb.3040153
Papers
Downstream and into deep biology: Evolving business models in 'top tier' genomics companies
Harry Rothman and Alison Kraft
J Commer Biotechnol 12: 86-98; doi:10.1057/palgrave.jcb.3040154
The new tax rules for university spin-outs: An answer to all the problems?
Alison Hughes and Joanne Brien
J Commer Biotechnol 12: 99-104; doi:10.1057/palgrave.jcb.3040155
The convergence of biotechnology and nanotechnology: Why here, why now?
Tom C Thomas and Rachelle Acuña-Narvaez
J Commer Biotechnol 12: 105-110; doi:10.1057/palgrave.jcb.3040156
The development of the South African biotech sector
Britt Akermann and Faiz Kermani
J Commer Biotechnol 12: 111-119; doi:10.1057/palgrave.jcb.3040157
Stem cell patenting
Claire Baldock
J Commer Biotechnol 12: 120-126; doi:10.1057/palgrave.jcb.3040158
The dismantling of redundant dichotomies: Biotechnology as an exemplar of university–industry collaboration
Michael J Lynskey
J Commer Biotechnol 12: 127-147; doi:10.1057/palgrave.jcb.3040159
Growth drivers and resistors of the influenza market: The importance of cell culture flu
Mark Belsey, David Evans, Alex Pavlou and John Savopoulos
J Commer Biotechnol 12: 150-155; doi:10.1057/palgrave.jcb.3040160
Legal and regulatory update
J Commer Biotechnol 12: 157-171; doi:10.1057/palgrave.jcb.3040161
